On January 16, 2026, NovaBay Pharmaceuticals, Inc. entered a Securities Purchase Agreement, raising about $134 million by issuing pre-funded warrants for 837,696,130 shares at $0.17 each, allowing later exercise at $0.01 per share, subject to stockholder approval.